相关实验视频
Updated: May 11, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.1K
对帕金森病下尿路症状的电刺激与保守治疗的有效性:一个三臂随机对照试验协议
Dorien Bennink1, Rob A de Bie2, Henk W Elzevier1
1Department of Urology, Leiden University Medical Center, Leiden, the Netherlands.
Contemporary clinical trials communications
|April 17, 2025
概括
这项研究研究了电刺激与帕金森病的保守治疗相结合的情况.
科学领域:
- 神经学 神经学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 物理疗法物理治疗
背景情况:
- 下尿路症状 (LUTS) 影响27-85%的帕金森病患者.
- 尿急,失禁,频率和夜尿是PD中常见的LUTS.
- 在PD中对LUTS的基于证据的治疗方法有限.
研究的目的:
- 为了评估电刺激的疗效与保守的治疗结合在PD患者的LUTS.
- 将不同的电刺激参数 (小脉冲和宽脉冲持续时间) 与假刺激进行比较.
- 评估对尿路症状,膀功能障碍,负担和生活质量的影响.
主要方法:
- 随机对照试验,包括150名患有LUTS的PD患者.
- 三只手臂:保守治疗,脉冲持续时间小,脉冲持续时间宽,或假电刺激.
- 主要结局:12周国际前列腺症状评分 (IPSS) 的变化.
主要成果:
- 该研究旨在检测IPSS中4.2的最小重要差异 (p<0.05).
- 二次结果包括关于膀功能,负担和生活质量的验证问卷.
- 骨盆底肌功能将在基线和12周评估.
结论:
- 这项试验将提供关于电刺激对帕金森病中的LUTS有效性的关键数据.
- 这些发现将为临床实践提供信息,并可能扩大LUTSPD患者的治疗选择.
- 这项研究旨在确定最佳的电刺激参数,以在这个人群中管理LUTS.
更多相关视频
11:34Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
Published on: January 10, 2013
22.9K
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.6K
相关概念视频
Parkinson's Disease: Treatment
152
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
152
Electroconvulsive Therapy
18
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
18
Parkinson's Disease: Overview
311
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
311